Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma (RAD001)

This study has been completed.
Information provided by (Responsible Party):
Susan Chang, University of California, San Francisco Identifier:
First received: January 13, 2009
Last updated: February 16, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)